ID   PARP2_HUMAN             Reviewed;         583 AA.
AC   Q9UGN5; Q8TEU4; Q9NUV2; Q9UMR4; Q9Y6C8;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   26-SEP-2001, sequence version 2.
DT   10-MAY-2017, entry version 167.
DE   RecName: Full=Poly [ADP-ribose] polymerase 2;
DE            Short=PARP-2;
DE            Short=hPARP-2;
DE            EC=2.4.2.30;
DE   AltName: Full=ADP-ribosyltransferase diphtheria toxin-like 2;
DE            Short=ARTD2;
DE   AltName: Full=NAD(+) ADP-ribosyltransferase 2;
DE            Short=ADPRT-2;
DE   AltName: Full=Poly[ADP-ribose] synthase 2;
DE            Short=pADPRT-2;
GN   Name=PARP2; Synonyms=ADPRT2, ADPRTL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Fetal brain;
RX   PubMed=10364231; DOI=10.1074/jbc.274.25.17860;
RA   Ame J.-C., Rolli V., Schreiber V., Niedergang C., Apiou F., Decker P.,
RA   Muller S., Hoeger T., Menissier-de Murcia J., de Murcia G.M.;
RT   "PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose)
RT   polymerase.";
RL   J. Biol. Chem. 274:17860-17868(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-583 (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=10329013; DOI=10.1006/geno.1999.5799;
RA   Johansson M.;
RT   "A human poly(ADP-ribose) polymerase gene family (ADPRTL): cDNA
RT   cloning of two novel poly(ADP-ribose) polymerase homologues.";
RL   Genomics 57:442-445(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 22-583 (ISOFORM 1).
RC   TISSUE=Fibroblast;
RX   PubMed=10338144; DOI=10.1016/S0014-5793(99)00448-2;
RA   Berghammer H., Ebner M., Marksteiner R., Auer B.;
RT   "pADPRT-2: a novel mammalian polymerizing(ADP-ribosyl)transferase gene
RT   related to truncated pADPRT homologues in plants and Caenorhabditis
RT   elegans.";
RL   FEBS Lett. 449:259-263(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ASN-161; SER-168;
RP   GLY-235; VAL-285 AND GLN-296.
RG   NIEHS SNPs program;
RL   Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   INTERACTION WITH PARP1; XRCC1; POLB AND LRIG3.
RX   PubMed=11948190; DOI=10.1074/jbc.M202390200;
RA   Schreiber V., Ame J.-C., Dolle P., Schultz I., Rinaldi B., Fraulob V.,
RA   Menissier-de Murcia J., de Murcia G.M.;
RT   "Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base
RT   excision DNA repair in association with PARP-1 and XRCC1.";
RL   J. Biol. Chem. 277:23028-23036(2002).
RN   [7]
RP   NOMENCLATURE.
RX   PubMed=20106667; DOI=10.1016/j.tibs.2009.12.003;
RA   Hottiger M.O., Hassa P.O., Luscher B., Schuler H., Koch-Nolte F.;
RT   "Toward a unified nomenclature for mammalian ADP-
RT   ribosyltransferases.";
RL   Trends Biochem. Sci. 35:208-219(2010).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226 AND SER-232, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   INTERACTION WITH HPF1.
RX   PubMed=27067600; DOI=10.1016/j.molcel.2016.03.008;
RA   Gibbs-Seymour I., Fontana P., Rack J.G., Ahel I.;
RT   "HPF1/C4orf27 is a PARP-1-interacting protein that regulates PARP-1
RT   ADP-ribosylation activity.";
RL   Mol. Cell 62:432-442(2016).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH HPF1.
RX   PubMed=28190768; DOI=10.1016/j.molcel.2017.01.003;
RA   Bonfiglio J.J., Fontana P., Zhang Q., Colby T., Gibbs-Seymour I.,
RA   Atanassov I., Bartlett E., Zaja R., Ahel I., Matic I.;
RT   "Serine ADP-ribosylation depends on HPF1.";
RL   Mol. Cell 0:0-0(2017).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 235-579 IN COMPLEX WITH PARP
RP   INHIBITORS, AND SUBUNIT.
RX   PubMed=20092359; DOI=10.1021/bi902079y;
RA   Karlberg T., Hammarstrom M., Schutz P., Svensson L., Schuler H.;
RT   "Crystal structure of the catalytic domain of human PARP2 in complex
RT   with PARP inhibitor ABT-888.";
RL   Biochemistry 49:1056-1058(2010).
CC   -!- FUNCTION: Involved in the base excision repair (BER) pathway, by
CC       catalyzing the poly(ADP-ribosyl)ation of a limited number of
CC       acceptor proteins involved in chromatin architecture and in DNA
CC       metabolism (PubMed:10364231, PubMed:28190768). This modification
CC       follows DNA damages and appears as an obligatory step in a
CC       detection/signaling pathway leading to the reparation of DNA
CC       strand breaks (PubMed:10364231). Mediates serine ADP-ribosylation
CC       of target proteins following interaction with HPF1; HPF1
CC       conferring serine specificity (PubMed:28190768).
CC       {ECO:0000269|PubMed:10364231, ECO:0000269|PubMed:28190768}.
CC   -!- CATALYTIC ACTIVITY: NAD(+) + (ADP-D-ribosyl)(n)-acceptor =
CC       nicotinamide + (ADP-D-ribosyl)(n+1)-acceptor.
CC       {ECO:0000255|PROSITE-ProRule:PRU00397}.
CC   -!- SUBUNIT: Component of a base excision repair (BER) complex,
CC       containing at least XRCC1, PARP1, POLB and LRIG3 (By similarity).
CC       Homo- and heterodimer with PARP1 (PubMed:20092359). Interacts
CC       weakly (via the PARP catalytic domain) with HPF1 (PubMed:27067600,
CC       PubMed:28190768). {ECO:0000250|UniProtKB:O88554,
CC       ECO:0000269|PubMed:20092359, ECO:0000269|PubMed:27067600,
CC       ECO:0000269|PubMed:28190768}.
CC   -!- INTERACTION:
CC       Q00688:FKBP3; NbExp=2; IntAct=EBI-2795348, EBI-1044081;
CC       Q99469:STAC; NbExp=2; IntAct=EBI-2795348, EBI-2652799;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10364231}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UGN5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UGN5-2; Sequence=VSP_004537;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed, mainly in actively dividing
CC       tissues. The highest levels are in the brain, heart, pancreas,
CC       skeletal muscle and testis; also detected in kidney, liver, lung,
CC       placenta, ovary and spleen; levels are low in leukocytes, colon,
CC       small intestine, prostate and thymus.
CC   -!- PTM: Poly-ADP-ribosylated by PARP1.
CC       {ECO:0000250|UniProtKB:O88554}.
CC   -!- PTM: Acetylation reduces DNA binding and enzymatic activity.
CC       {ECO:0000250|UniProtKB:O88554}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD29857.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAL77437.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAB41505.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/adprtl2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ236912; CAB65088.1; -; mRNA.
DR   EMBL; AF085734; AAD29857.1; ALT_INIT; mRNA.
DR   EMBL; AJ236876; CAB41505.2; ALT_INIT; mRNA.
DR   EMBL; AK001980; BAA92017.1; ALT_TERM; mRNA.
DR   EMBL; AF479321; AAL77437.1; ALT_SEQ; Genomic_DNA.
DR   CCDS; CCDS41910.1; -. [Q9UGN5-1]
DR   CCDS; CCDS45077.1; -. [Q9UGN5-2]
DR   RefSeq; NP_001036083.1; NM_001042618.1. [Q9UGN5-2]
DR   RefSeq; NP_005475.2; NM_005484.3. [Q9UGN5-1]
DR   UniGene; Hs.409412; -.
DR   PDB; 3KCZ; X-ray; 2.00 A; A/B=235-579.
DR   PDB; 3KJD; X-ray; 1.95 A; A/B=235-579.
DR   PDB; 4PJV; X-ray; 2.50 A; A/B=235-579.
DR   PDB; 4TVJ; X-ray; 2.10 A; A/B=235-579.
DR   PDB; 4ZZX; X-ray; 1.65 A; A/B=223-583.
DR   PDB; 4ZZY; X-ray; 2.20 A; A=223-583.
DR   PDB; 5D5K; X-ray; 1.90 A; B=1-91.
DR   PDB; 5DSY; X-ray; 2.70 A; A/B/C/D=348-583.
DR   PDBsum; 3KCZ; -.
DR   PDBsum; 3KJD; -.
DR   PDBsum; 4PJV; -.
DR   PDBsum; 4TVJ; -.
DR   PDBsum; 4ZZX; -.
DR   PDBsum; 4ZZY; -.
DR   PDBsum; 5D5K; -.
DR   PDBsum; 5DSY; -.
DR   ProteinModelPortal; Q9UGN5; -.
DR   SMR; Q9UGN5; -.
DR   BioGrid; 115350; 46.
DR   DIP; DIP-48934N; -.
DR   IntAct; Q9UGN5; 57.
DR   MINT; MINT-7914677; -.
DR   STRING; 9606.ENSP00000250416; -.
DR   BindingDB; Q9UGN5; -.
DR   ChEMBL; CHEMBL5366; -.
DR   DrugBank; DB09074; Olaparib.
DR   DrugBank; DB07232; Veliparib.
DR   GuidetoPHARMACOLOGY; 2772; -.
DR   iPTMnet; Q9UGN5; -.
DR   PhosphoSitePlus; Q9UGN5; -.
DR   BioMuta; PARP2; -.
DR   DMDM; 17380230; -.
DR   EPD; Q9UGN5; -.
DR   PaxDb; Q9UGN5; -.
DR   PeptideAtlas; Q9UGN5; -.
DR   PRIDE; Q9UGN5; -.
DR   DNASU; 10038; -.
DR   Ensembl; ENST00000250416; ENSP00000250416; ENSG00000129484. [Q9UGN5-1]
DR   Ensembl; ENST00000429687; ENSP00000392972; ENSG00000129484. [Q9UGN5-2]
DR   GeneID; 10038; -.
DR   KEGG; hsa:10038; -.
DR   UCSC; uc001vxc.4; human. [Q9UGN5-1]
DR   CTD; 10038; -.
DR   DisGeNET; 10038; -.
DR   GeneCards; PARP2; -.
DR   HGNC; HGNC:272; PARP2.
DR   HPA; HPA052003; -.
DR   MIM; 607725; gene.
DR   neXtProt; NX_Q9UGN5; -.
DR   OpenTargets; ENSG00000129484; -.
DR   PharmGKB; PA24592; -.
DR   eggNOG; KOG1037; Eukaryota.
DR   eggNOG; ENOG410XP18; LUCA.
DR   GeneTree; ENSGT00390000017341; -.
DR   HOGENOM; HOG000173055; -.
DR   HOVERGEN; HBG053514; -.
DR   InParanoid; Q9UGN5; -.
DR   KO; K10798; -.
DR   OMA; ACSGDLN; -.
DR   OrthoDB; EOG091G13H1; -.
DR   PhylomeDB; Q9UGN5; -.
DR   TreeFam; TF315407; -.
DR   BRENDA; 2.4.2.30; 2681.
DR   Reactome; R-HSA-110362; POLB-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-HSA-5685939; HDR through MMEJ (alt-NHEJ).
DR   Reactome; R-HSA-5696394; DNA Damage Recognition in GG-NER.
DR   Reactome; R-HSA-5696395; Formation of Incision Complex in GG-NER.
DR   Reactome; R-HSA-5696400; Dual Incision in GG-NER.
DR   SIGNOR; Q9UGN5; -.
DR   ChiTaRS; PARP2; human.
DR   EvolutionaryTrace; Q9UGN5; -.
DR   GeneWiki; PARP2; -.
DR   GenomeRNAi; 10038; -.
DR   PRO; PR:Q9UGN5; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000129484; -.
DR   CleanEx; HS_PARP2; -.
DR   ExpressionAtlas; Q9UGN5; baseline and differential.
DR   Genevisible; Q9UGN5; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003910; F:DNA ligase (ATP) activity; IBA:GO_Central.
DR   GO; GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:1990404; F:protein ADP-ribosylase activity; IDA:UniProtKB.
DR   GO; GO:0006284; P:base-excision repair; IEA:Ensembl.
DR   GO; GO:0051103; P:DNA ligation involved in DNA repair; IBA:GO_Central.
DR   GO; GO:0006281; P:DNA repair; TAS:ProtInc.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0006273; P:lagging strand elongation; IBA:GO_Central.
DR   GO; GO:0018312; P:peptidyl-serine ADP-ribosylation; IDA:UniProtKB.
DR   GO; GO:0006471; P:protein ADP-ribosylation; TAS:ProtInc.
DR   Gene3D; 1.20.142.10; -; 1.
DR   Gene3D; 2.20.140.10; -; 1.
DR   InterPro; IPR012317; Poly(ADP-ribose)pol_cat_dom.
DR   InterPro; IPR004102; Poly(ADP-ribose)pol_reg_dom.
DR   InterPro; IPR008893; WGR_domain.
DR   Pfam; PF00644; PARP; 1.
DR   Pfam; PF02877; PARP_reg; 1.
DR   Pfam; PF05406; WGR; 1.
DR   SMART; SM00773; WGR; 1.
DR   SUPFAM; SSF142921; SSF142921; 1.
DR   SUPFAM; SSF47587; SSF47587; 1.
DR   PROSITE; PS51060; PARP_ALPHA_HD; 1.
DR   PROSITE; PS51059; PARP_CATALYTIC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   DNA-binding; Glycosyltransferase; NAD; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase.
FT   CHAIN         1    583       Poly [ADP-ribose] polymerase 2.
FT                                /FTId=PRO_0000211327.
FT   DOMAIN      231    348       PARP alpha-helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00398}.
FT   DOMAIN      356    583       PARP catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00397}.
FT   DNA_BIND      1     88       {ECO:0000255}.
FT   MOTIF         4      7       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOTIF        35     40       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOD_RES      37     37       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:O88554}.
FT   MOD_RES      38     38       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:O88554}.
FT   MOD_RES     226    226       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     232    232       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   VAR_SEQ      68     80       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10364231}.
FT                                /FTId=VSP_004537.
FT   VARIANT     161    161       S -> N (in dbSNP:rs3093905).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_019174.
FT   VARIANT     168    168       N -> S (in dbSNP:rs3093906).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_019175.
FT   VARIANT     235    235       D -> G (in dbSNP:rs3093921).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_019176.
FT   VARIANT     285    285       I -> V (in dbSNP:rs3093925).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_019177.
FT   VARIANT     296    296       R -> Q (in dbSNP:rs3093926).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_019178.
FT   VARIANT     331    331       I -> T (in dbSNP:rs2275010).
FT                                /FTId=VAR_050462.
FT   CONFLICT    447    447       P -> H (in Ref. 2; AAD29857).
FT                                {ECO:0000305}.
FT   CONFLICT    481    481       N -> H (in Ref. 4; BAA92017).
FT                                {ECO:0000305}.
FT   HELIX       236    245       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       248    257       {ECO:0000244|PDB:4ZZX}.
FT   TURN        262    264       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       267    269       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       272    290       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       296    308       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       324    346       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       357    365       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      367    371       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       377    388       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      397    409       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       412    415       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      423    429       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       432    434       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       435    441       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       452    454       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      459    466       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       467    471       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       472    474       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      478    480       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      482    491       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      494    500       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       505    508       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      514    517       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      519    523       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       525    527       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      529    531       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      534    536       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      541    543       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      549    551       {ECO:0000244|PDB:3KJD}.
FT   STRAND      554    556       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      558    563       {ECO:0000244|PDB:4ZZX}.
FT   HELIX       564    566       {ECO:0000244|PDB:4ZZX}.
FT   STRAND      567    579       {ECO:0000244|PDB:4ZZX}.
SQ   SEQUENCE   583 AA;  66206 MW;  5B7AE8AE531836AF CRC64;
     MAARRRRSTG GGRARALNES KRVNNGNTAP EDSSPAKKTR RCQRQESKKM PVAGGKANKD
     RTEDKQDGMP GRSWASKRVS ESVKALLLKG KAPVDPECTA KVGKAHVYCE GNDVYDVMLN
     QTNLQFNNNK YYLIQLLEDD AQRNFSVWMR WGRVGKMGQH SLVACSGNLN KAKEIFQKKF
     LDKTKNNWED REKFEKVPGK YDMLQMDYAT NTQDEEETKK EESLKSPLKP ESQLDLRVQE
     LIKLICNVQA MEEMMMEMKY NTKKAPLGKL TVAQIKAGYQ SLKKIEDCIR AGQHGRALME
     ACNEFYTRIP HDFGLRTPPL IRTQKELSEK IQLLEALGDI EIAIKLVKTE LQSPEHPLDQ
     HYRNLHCALR PLDHESYEFK VISQYLQSTH APTHSDYTMT LLDLFEVEKD GEKEAFREDL
     HNRMLLWHGS RMSNWVGILS HGLRIAPPEA PITGYMFGKG IYFADMSSKS ANYCFASRLK
     NTGLLLLSEV ALGQCNELLE ANPKAEGLLQ GKHSTKGLGK MAPSSAHFVT LNGSTVPLGP
     ASDTGILNPD GYTLNYNEYI VYNPNQVRMR YLLKVQFNFL QLW
//
